Venetoclax Combining Chidamide and Azacitidine (VCA) in the Treatment of R/R AML | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Venetoclax Combining Chidamide and Azacitidine (VCA) in the Treatment of R/R AML	Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, hematologic disorder, leukemia, myeloid leukemia, neoplasm	Recruiting	Phase 2	2025-09-11		NCT05305859

7 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Dongguan People's Hospital	32
Fujian Cancer Hospital	114
Fujian Provincial Hospital	45
Huizhou Municipal Central Hospital	21
Jieyang People's Hospital	14
The First Affiliated Hospital of Xiamen University	107
Zhangzhou Municipal Hospital of Fujian Province	10

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Bing Xu	Xiamen	China	4